Shilpa Medicare opened higher at ₹964.00, compared with its previous close of ₹942.35. In the last trading session on 8 Nov 2026, the stock traded between ₹927.00 and ₹968.00, with an average traded price of ₹950.79. It showed an upward intraday trend.
An investment of ₹10,000 made 5 years ago in Shilpa Medicare is now worth
₹ 30,790.00
giving a profit of
₹ 20,790.00 (207.90%)
Note: Past profits do not guarantee future returns.
Rating by Refinitive from 4 Analysts
Today's Change
+11.30 (+1.20%)
Day High
₹968.00
Day Low
₹927.00
Day Open
₹964.00
Prev Close
₹942.35
Volume
2,66,076
Value Traded
₹25.30 Cr
1W Return
-0.20%
1M Return
-11.18%
3M Return
29.08%
6M Return
115.81%
1Y Return
158.65%
Market Cap (₹ Cr.)
18,652
PE Ratio
55.40
PB Ratio
6.68
Dividend Yield
0.06%
ROE
9.39%
ROCE
12.39%
Book Value (₹)
141.00
Face Value (₹)
1.00
EPS (TTM)
4.05
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-0.20%
6 Weeks
-
1 Month
-11.18%
3 Months
29.08%
9 Months
201.88%
Shilpa Medicare Q2FY27 net profit rises 80% YoY to ₹79 crore
Net profit rose 80% YoY to ₹79.2 crore in Q2FY27. Revenue increased 45% YoY to ₹538 crore. API segment contributed 47% to total revenue with record quarterly sales. EBITDA margin contracted 200 bps to 28% despite profit growth.
4 days agoNCLAT sets aside CIRP order on Shilpa Medicare subsidiary FTF Pharma
NCLAT set aside the NCLT order initiating CIRP on FTF Pharma Private Limited. Tribunal found a plausible pre-existing dispute existed before the demand notice. Total claim of ₹2,18,03,319 related to Technology Transfer Agreement was contested. Management powers restored to FTF Pharma Board of Directors with immediate effect.
4 days agoShilpa Medicare secures Europe GMP approval for Jadcherla Unit 4
Shilpa Medicare secured European GMP certification for its Jadcherla Unit 4 from AGES Austria. Inspection by AGES was conducted between July 27 and July 30, 2026. Certification covers sterile injections, non-sterile tablets, and non-sterile capsules. Approval supports export market compliance for European and global regions.
28 days agoShilpa Medicare promoter group releases pledge on 30 lakh shares
Promoter group released encumbrance on 30,00,000 shares (1.5337% of capital). Release occurred on September 25, 2026, involving pledges with Bajaj Finance Limited. Vishnukant C Bhutada had the largest release at 10,00,000 shares. Remaining encumbered shares persist for key promoters like Deepak Kumar Innani.
1mo agoShilpa Medicare to participate in Nuvama CEO Forum on Sep 28, 2026
Shilpa Medicare officials will attend the Nuvama Emerging India CEO Forum on September 28, 2026. Meetings in Mumbai will include both one-on-one and group sessions with investors. The company confirmed that no Unpublished Price Sensitive Information will be disclosed. Participation is reported under SEBI Listing Regulations for investor conferences.
1mo agoShilpa Medicare's Hyderabad unit gets one remark in USFDA inspection
Shilpa Medicare's Hyderabad unit underwent a USFDA surveillance inspection. The facility received one procedural observation during the review. The finding relates to a process-level issue at the Analytical Services Division. Standard regulatory procedure requires submission of a corrective action plan.
1mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,904.50 | -0.55% | ₹4,56,953.35 | 41.80 | +12.60% | |
| ₹11,565.50 | +4.22% | ₹3,07,027.69 | 87.50 | +73.75% | |
| ₹4,780.00 | +0.15% | ₹1,81,815.84 | 86.50 | +33.52% | |
| ₹2,454.00 | +3.54% | ₹1,32,592.62 | 96.10 | +149.86% | |
| ₹1,215.90 | +1.37% | ₹1,21,286.49 | 27.80 | +28.79% | |
| ₹1,385.00 | +1.09% | ₹1,15,603.22 | 41.40 | +14.90% | |
| ₹1,403.80 | -0.14% | ₹1,13,407.17 | 40.00 | -6.77% | |
| ₹2,668.30 | +3.31% | ₹1,10,212.82 | 47.00 | +17.97% | |
| ₹1,855.30 | +2.84% | ₹1,06,749.86 | 26.10 | +65.09% | |
| ₹2,025.00 | +1.40% | ₹92,601.22 | 17.50 | +2.70% | |
| ₹2,671.10 | +2.94% | ₹75,385.03 | 50.50 | +47.45% | |
| ₹5,398.50 | +1.78% | ₹64,547.17 | 28.80 | -4.76% |
An investment of ₹10,000 made 5 years ago in Shilpa Medicare is now worth
₹ 30,790.00
giving a profit of
₹ 20,790.00 (207.90%)
Note: Past profits do not guarantee future returns.